Form D · Other Health Care
TICI 3 Therapeutics, Inc.
Knoxville, TN · CIK 0001866761
Offering snapshot reported Jun 10, 2021 · SEC filing
- Reported sold
- $50K Indefinite offering
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $5K Reported outside-investor minimum
- First sale
- May 27, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 10, 2021 | Initial | $50,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-402380
Simple agreement for future equity (SAFE), the capital stock of issuer into which the SAFE may convert (SAFE Shares), and the capital stock of issuer into which the SAFE Shares may convert.
Source: Form D, filed Jun 10, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Andrew Nicholson | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
382 Axton Dr.
Knoxville, TN, 37934
Knoxville, TN, 37934